COVİD-19 HASTALARINDA İŞİTME KAYBI

Amaç Dünya çapında bilim insanları, COVID-19'dan iyileşen hastaları takip etmeye devam ediyorlar. Bu hastalarda gözlemlenen uzun süreli kalıcı semptomları ve kalıcı hasarları yayınlıyorlar. Bu çalışma, saf ses odyomet- risi kullanılarak ölçülen saf ses ortalamaları temelinde COVID-19 hastalarında işitme kaybını değerlendir- meyi amaçladı. Gereç ve Yöntem Bu geriye dönük veri analizi çalışmasında, CO- VID-19'lu hastaneye yatırılmamış hastaların saf ses ortalamaları, COVID-19'a yakalanmadan 1 yıl önce ve sonra karşılaştırıldı. Sürekli değişkenler ortalama ± standart sapma (SD) olarak, kategorik değişkenler ise sayı (n) ve yüzde (%) olarak sunuldu. Tüm veriler normal dağılım gösterdi. Bu nedenle, ölçümler arasın- daki anlamlı farklılıkları belirlemek için bir parametrik test türü olan eşleştirilmiş t testi kullanılmıştır. Bulgular Sol ve sağ kulakların kemik ve hava yollarında ölçü- len saf ses ortalamalarına göre, COVID-19 sonrası hastaların saf ses eşik değerlerinde anlamlı bir artış bulundu (tümü için p

HEARING LOSS IN PATIENTS WITH COVID-19

Objective Worldwide, scientists continue to follow-up on patients recovered from COVID-19 and have published the long-term persistent symptoms and permanent damage observed in various tissues. The present study aimed to evaluate hearing loss in patients with COVID-19 on the basis of pure tone averages measured using pure tone audiometry. Material and Method In this retrospective data analysis study, pure tone averages of non-hospitalised patients with COVID-19 were compared over 1 year before and after contracting COVID-19. Continuous variables were presented as mean ± Standard deviation (SD) and categorical variables were presented as number (n) and percentage (%). All data showed normal distribution. Therefore, paired t-test, a type of parametric test, was used to identify the significant differences between the measurements. Results The pure tone threshold values of patients increased significantly after COVID-19 (p0.001 for all) based on puretone averages measured in the bones and airways of theleftandrightears. Olderadults (41–64 yearsold) had a greater difference in puretone averages of the left ear airway before and after COVID-19 (p=0.040) than younger adults (18–40 yearsold). Conclusion COVID-19 affects both ears' bones and airways, causing varying degrees of hearing loss at different frequencies. Hearing loss tests should be included in COVID-19 complications research, and clinicians should be given advice on how to avoid hearing loss.

___

  • 1. Li K, Wu J, Wu F, et al. The Clinical and Chest CT Features Associated with Severe and Critical COVID-19 Pneumonia. Invest Radiol.2020;55(6):327-31. doi:10.1097/RLI.0672
  • 2. Ahmad I, Rathore FA. Neurological manifestations and comp- lications of COVID-19: A Literature Review. J ClinNeurosci. 2020;13(5):667-73.doi: 10.1016/j.jiph.2020.03.019
  • 3. Leonardi M, Padovani A, McArthur JC. Neurological manifestations associated with COVID19: a review and a call for action. J Neurol. 2020;267(6):1573-6.
  • 4. Li B, Yang J, Zhao F, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. ClinRes- Cardiol. 2020;109(5):531 8. doi:10.1007/s00392-020-01626-9
  • 5. Hunt RH, East JE, Lanas A, et al. COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist. Dig- Dis2021;39:119-39. doi: 10.1159/000512152
  • 6. TR. Ministry of Health Covid-19 patients follow-up guide, 2021. Accessed from::https://toraks.org.tr/site/sf/nmf/pre_migration/ 0cd6655ae86e94eec61e88ab75cc757d8eaa1df39ce- 43d3c871b3d715afde5b6.pdf. Accessed time: 05.06.2021
  • 7. Chen X, Fu YY, Zhang TY. Role of Viral infection in sudden hearing loss. J IntMedRes. 2019;47(7):2865–72. doi: 10.1177/0300060519847860.
  • 8. TR. Ministry of Family, Laborand Social Security. Health and surve illance guide in working life, 2018. Accessed from: https:// www.ailevecalisma.gov.tr/medias/4591/rehber03.pdf. Accessed time: 05.06.2021
  • 9. Mustafa MW. Audiological profile of asymptomatic Covid-19 PCR-positive cases. Am J Otolaryngol. 2020;41(3) doi: 10.1016/j.amjoto.2020.102483.
  • 10. Karimi-Galougahi M, Naeini AS, Raad N, et al. Vertigo and hearing loss during the COVID-19 pandemic - is there an association? ActaOtorhinolaryngolItal. 2020;40:463-5. doi: 10.14639/0392-100X-N0820
  • 11. Koumpa FS, Forde CT, Manjaly JG. Sudden irreversible hearing loss post COVID-19. BMJ Case Reports CP 2020;13,13(11):e238419 doi:10.1136/bcr-2020-238419.
  • 12. Sriwijitalai W, Wiwanitkit V. Hearing loss and COVID-19: A note. AmericanJournal of Otolaryngology -Head and Neck Medicine and Surgery;2020;41(3). doi:10.1016/j.amjoto.2020.102473
  • 13. Han W, Quan B, Guo Y, et al. The course of clinical diagnosis and treatment of a case infected with coronavirus disease 2019. Journal of Medical Virology.2020;92(5):461-3. doi:10.1002/ jmv.25711
  • 14. Kim J, Jung J, Moon IS, Lee HK, Lee WS. Statistical analysis of puretone audiometry and caloric test in herpes zosteroticus. ClinExpOtorhinolaryngol. 2008;1(1):15-9.
  • 15. Kim CH, Choi H, Shin JE. Characteristics of hearing loss in patients with herpes zosteroticus. Medicine (Baltimore). 2016;95(46):e5438.
  • 16. Acharya A, Kevadiya BD, Gendelman HE, Byrareddy SN. SARSCoV- 2 Infection Leads to Neurological Dysfunction. J NeuroimmunePharmacol2020; 15:167–73.
  • 17. Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, vanGoor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203(2):631-7. doi: 10.1002/ path.1570.
  • 18. Iroegbu JD, Ifenatuoha CW. Ijomone OM. Potential neurological impact of coronaviruses: implications for the novel SARSCoV- 2. NeurolSci. 2020;41(6):1329-37.
  • 19. Kalcioglu MT, Cag Y, Kilic O, Tuysuz O. COVID-19 cause sudden sensorineural hearing loss? Int J Infect Dis.2020;101:205 doi:10.1016/j.ijid.2020.09.1468.
  • 20. Maharaj S, BelloAlvarez M, Mungul S, Hari K. Otologic dysfunction in patients with COVID-19: a systematic review. LaryngoscopeInvestigOtolaryngol.2020;5(6):1192–6. doi: 10.1002/ lio2.498.
  • 21. Saniasiaya J. Hearing loss in SARS-CoV-2: What do we know? EarNoseThroat J. 2020;100(2):152-4. doi: 10.1177/0145561320946902.
  • 22. Taneja MK. Deafness in COVID-19. Indian J Otol. 2020;26(2):68- 70 doi:10.4103/indianjotol.INDIANJOTOL_83_20
  • 23. Yaseen N K, Al-Ani R M, Ali Rashid R. COVID-19-related sudden sensorineural hearing loss. Qatar medical journal, 2021(3), 58. https://doi.org/10.5339/qmj.2021.58
  • 24. Edwards M, Muzaffar J, Naik P, Coulson C. Catastrophic bilateral sudden sensorineural hearing loss following COVID-19. BMJ Case Rep. 2021 ;14(6):e243157. doi: 10.1136/bcr-2021- 243157.
  • 25. 25. Koumpa F S, Forde C T, Manjaly J G. Sudden irreversible hearing loss post COVID-19. BMJ case reports 2020;13(11); e238419. https://doi.org/10.1136/bcr-2020-238419
Süleyman Demirel Üniversitesi Tıp Fakültesi Dergisi-Cover
  • ISSN: 1300-7416
  • Yayın Aralığı: 4
  • Başlangıç: 1994
  • Yayıncı: SDÜ Basımevi / Isparta
Sayıdaki Diğer Makaleler

ŞİZOFRENİ HASTALARINDA YAPILANDIRILMIŞ EGZERSİZ PROGRAMININ YAŞAM VE UYKU KALİTESİNE ETKİSİ

Tuba KORKMAZ ASLAN, Mine EKİNCİ

ÖĞRETMENLERDE SAĞLIKLI YAŞAM BİÇİMİ DAVRANIŞLARI: DİYARBAKIR İLİ SİLVAN İLÇESİ ÖRNEĞİ

Ayşe ÇELİK, Pınar ERSOY

ÇÖLYAK HASTALIĞININ GEBELİK SONUÇLARI ÜZERİNDEKİ ETKİSİ

Ayşe KELEŞ, Gülşah DAĞDEVİREN, Özge YÜCEL ÇELİK, Cantekin İSKENDER, Gül ÖZGEN, Şevki ÇELEN

MAJÖR DEPRESİF BOZUKLUKTA NÖTROFİL LENFOSİT ORANI, TROMBOSİT LENFOSİT ORANI VE ORTALAMA TROMBOSİT HACMİ DEĞERLENDİRİLMESİ

Süleyman KORKUT

COVID-19 PANDEMİSİNİ TAKİBEN KOLOREKTAL KARSİNOM VAKALARININ DEMOGRAFİK VE KLİNİK ÖZELLİKLERİNDE MEYDANA GELEN DEĞİŞİKLİKLER

Dursun Burak ÖZDEMİR, Ahmet KARAYİĞİT, Hayrettin DİZEN, Bülent ÜNAL

COVİD-19 HASTALARINDA İŞİTME KAYBI

Gökmen ÖZCEYLAN, Dilek TOPRAK

SİLDENAFİL SİTRAT VE DEKSPANTENOLÜN YARA İYİLEŞMESİ ÜZERİNDEKİ ETKİLERİNİN KARŞILAŞTIRILMASI: DENEYSEL ÇALIŞMA

Musluh HAKSEVEN, Murat KAPAN, Ulaş ALABALIK, Gökhan AVŞAR

ATOPİK DERMATİT PATOGENEZİNDE MİR-1910-3P, MİR-4649-3P, MİR-4296 VE MİR-210'UN OLASI ROLÜ: MİR-4296 ATOPİK DERMATİT GELİŞİMİNDE ÖNEMLİ ROL OYNAYABİLİR Mİ?

Havva Hilal AYVAZ ÇELİK, Kuyaş HEKİMLER ÖZTÜRK, Emrah ATAY, İjlal ERTURAN, Selma KORKMAZ, Mehmet YILDIRIM

TİROİD İNCE İĞNE ASPİRASYONLARINDA İNCELENEN PREPARAT SAYISI İLE TANI ARASINDAKİ İLİŞKİ

Ayça TAN, Aydın İŞİSAĞ

BİPOLAR BOZUKLUK TANILI OLGULARDA HASTALIK ALGISININ KLİNİK ÖZELLİKLER, BAŞ ETME VE ÖZYETERLİLİK İLE İLİŞKİSİNİN İNCELENMESİ

Gülin ÖZDAMAR ÜNAL, Gizem Çağla AKTAŞ, Gökçe İŞCAN, İnci Meltem ATAY